Similarly, in the AChR-MG group, IS-treated patients (n: 17) showed higher IL-6 production than non-treated (n: 6, p = 0.038) and treated MuSK-MG patients (n: 11, p = 0.001, Fig 4C). The gene discussed is IL6; the disease is myasthenia gravis.